CULLINAN THERAPEUTICS, INC. (CGEM) Free cash flow 2020–2025
CULLINAN THERAPEUTICS, INC. (CGEM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$175.8MFY2025 · since FY2020: -$29.8M → -$175.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$175.8M | -21.0% |
| FY2024 | -$145.3M | -8.0% |
| FY2023 | -$134.5M | -5.2% |
| FY2022 | -$127.8M | -194.2% |
| FY2021 | -$43.4M | -45.8% |
| FY2020 | -$29.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice